Skip to main content
Default Image

From discovery to delivery: public sector development of the rVSV-ZEBOV Ebola vaccine

Citing The Democracy Collaborative’s Dana Brown on the need for a public option for pharmaceutics, this case study of rVSV-ZEBOV underscores the significant public contribution to the R&D of vaccines even under conditions of precarity, and suggests that an alternative approach to generating knowledge and developing interventions, such as open science, is required in order to fully realize the public sector’s contribution to improved global health.

“One option, which is gaining interest, is to create a ‘public option,’ that is, a public sector led supply of essential, affordably priced medicines from discovery all the way through manufacturing and regulatory approval.[55] Indeed, the case of rVSV-ZEBOV shows that such a public option is not simply theoretical; rather, as demonstrated by the NML, the public sector has the capacity to do much more than pure discovery research. Armed with sufficient resources, public sector labs can conduct phase 1, 2, and 3 clinical trials as well as solve many of the technical challenges that manufacturing a clinical grade vaccine will entail.”

Publication date: 2020-01-16
Parent publication: Journal of Law and the Biosciences
Publication URL: https://academic.oup.com/jlb/advance-article/doi/10.1093/jlb/lsz019/5706941

More related work

Default Image

The Democracy Collaborative and The Democracy Collaborative Workers' Union agree to fair severance package for laid-off staff

TDC and union members have agreed to a package of protections that goes well beyond the baseline severance provisions for layoffs agreed to in TDC’s union contract.

read more
Default Image

HAN Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health summit

Today the Healthcare Anchor Network (HAN) convened the Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health summit to catalyze the conversation around how the healthcare sector could collaborate to more intentionally onshore and localize production of PPE and other important supplies with emphasis on equity, sustainability, and supply chain resilience. HAN released a white paper “Reimagining Personal Protective Equipment (PPE) Supply Chains” that calls for national leadership and healthcare sector collaboration to create PPE production capacity for American sourced and manufactured supplies.

read more
Default Image

Reimagining Personal Protective Equipment (PPE) Supply Chains

The Democracy Collaborative prepared a report, created for the Healthcare Anchor Network, which details the current status of the supply chain of PPE, the market shifts caused by COVID-19, and the potential solutions to ensure capacity within US health systems for the future.

read more